ReviewBiology2025
Camel (
Review in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Desert Duo: A Narrative Review on How Camel Milk and Date Fruits Combat Oxidative Stress and Enhance Metabolic Health.Antioxidants (Basel, Switzerland) · 2026Review
- Food-Derived Antidiabetic Peptides as Multi-Target Systemic Regulators: A Comprehensive Review of Sources, Preparation, Mechanisms and Future Perspectives.Foods (Basel, Switzerland) · 2026Review
- Comparative Lipidomic Profiling of Camel and Cow Milk from a Shared Semi-Desert Pasture: Implications for Camel Adaptation to Arid Environments.Molecules (Basel, Switzerland) · 2026Article
- Camel Milk as a Functional Food: Nutritional Composition, Health-Promoting Benefits, and Safety Considerations.Food science & nutrition · 2026Review
- Maternal and Environmental Drivers of Trace Mineral Dynamics in Camel Dams and Neonates Across Regions and Seasons in Saudi Arabia.Life (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review highlights the anti-hyperglycemic and antidiabetic properties of camel and dromedary milk (CM). Diabetes mellitus poses a significant global health challenge, and strategies that reduce reliance on insulin or other medications could substantially improve patient management. CM could represent a promising complementary approach due to its established antidiabetic effects, which are supported by its unique biological characteristics. Compared to other common milks, such as bovine milk, CM contains higher concentrations of insulin. Its distinctive physicochemical and microstructural properties help protect insulin and other bioactive proteins from degradation in the gastrointestinal tract, thereby enhancing their intestinal absorption. Furthermore, peptides generated during CM protein digestion may exert direct or indirect effects on the liver and pancreas, contributing to improved glucose metabolism. These beneficial actions are further supported by CM's antioxidant and antilipidemic properties, which may help mitigate diabetes-related complications, including renal dysfunction and skin lesions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.